These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26440282)

  • 1. AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.
    Saito Y; Chapple RH; Lin A; Kitano A; Nakada D
    Cell Stem Cell; 2015 Nov; 17(5):585-96. PubMed ID: 26440282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
    He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.
    Pei S; Minhajuddin M; Adane B; Khan N; Stevens BM; Mack SC; Lai S; Rich JN; Inguva A; Shannon KM; Kim H; Tan AC; Myers JR; Ashton JM; Neff T; Pollyea DA; Smith CA; Jordan CT
    Cell Stem Cell; 2018 Jul; 23(1):86-100.e6. PubMed ID: 29910151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia.
    Sumitomo Y; Koya J; Nakazaki K; Kataoka K; Tsuruta-Kishino T; Morita K; Sato T; Kurokawa M
    Blood; 2016 Sep; 128(12):1614-24. PubMed ID: 27480114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.
    Hao X; Gu H; Chen C; Huang D; Zhao Y; Xie L; Zou Y; Shu HS; Zhang Y; He X; Lai X; Zhang X; Zhou BO; Zhang CC; Chen GQ; Yu Z; Yang Y; Zheng J
    Cell Metab; 2019 Apr; 29(4):950-965.e6. PubMed ID: 30581117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia.
    Jiang Y; Hu T; Wang T; Shi X; Kitano A; Eagle K; Hoegenauer KA; Konopleva MY; Lin CY; Young NL; Nakada D
    Blood; 2019 Dec; 134(24):2183-2194. PubMed ID: 31697807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia.
    Hu T; Li C; Zhang Y; Wang L; Peng L; Cheng H; Wang W; Chu Y; Xu M; Cheng T; Yuan W
    Biochem Biophys Res Commun; 2015 Apr; 459(4):692-8. PubMed ID: 25769952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells.
    Leyton JV; Williams B; Gao C; Keating A; Minden M; Reilly RM
    Leuk Res; 2014 Nov; 38(11):1367-73. PubMed ID: 25278187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.
    Chapellier M; Peña-Martínez P; Ramakrishnan R; Eriksson M; Talkhoncheh MS; Orsmark-Pietras C; Lilljebjörn H; Högberg C; Hagström-Andersson A; Fioretos T; Larsson J; Järås M
    Haematologica; 2019 Oct; 104(10):2006-2016. PubMed ID: 30819903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
    Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
    Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.
    Hein N; Cameron DP; Hannan KM; Nguyen NN; Fong CY; Sornkom J; Wall M; Pavy M; Cullinane C; Diesch J; Devlin JR; George AJ; Sanij E; Quin J; Poortinga G; Verbrugge I; Baker A; Drygin D; Harrison SJ; Rozario JD; Powell JA; Pitson SM; Zuber J; Johnstone RW; Dawson MA; Guthridge MA; Wei A; McArthur GA; Pearson RB; Hannan RD
    Blood; 2017 May; 129(21):2882-2895. PubMed ID: 28283481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
    Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
    Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches.
    Fernandes Â; Azevedo MM; Pereira O; Sampaio-Marques B; Paiva A; Correia-Neves M; Castro I; Ludovico P
    Oncotarget; 2015 Oct; 6(31):31428-40. PubMed ID: 25537507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.
    Rodriguez-Zabala M; Ramakrishnan R; Reinbach K; Ghosh S; Oburoglu L; Falqués-Costa A; Bellamkonda K; Ehinger M; Peña-Martínez P; Puente-Moncada N; Lilljebjörn H; Cammenga J; Pronk CJ; Lazarevic V; Fioretos T; Hagström-Andersson AK; Woods NB; Järås M
    Blood Adv; 2023 Sep; 7(18):5382-5395. PubMed ID: 37505194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy.
    You R; Hou D; Wang B; Liu J; Wang X; Xiao Q; Pan Z; Li D; Feng X; Kang L; Chen P; Huang H
    J Leukoc Biol; 2022 Aug; 112(2):299-311. PubMed ID: 34927743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Monophosphate Activated Protein Kinase (AMPK) enhances chemotherapy response in Acute Myeloid Leukemia (AML).
    Ghiraldeli L; Anderson R; Pladna K; Pardee TS
    Cancer Lett; 2022 Jun; 535():215659. PubMed ID: 35321842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia stem cells.
    Testa U
    Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.